Updated May. 10, 2013 at 1:17 p.m.

Premium Lock Vaccine firm Medicago develops H7N9 bird flu vaccine candidate

Published: 2013-05-10 12:20:00
Updated: 2013-05-10 13:17:57

How Medicago process works How Medicago's process works as explained in a graphic from the firm's website.

Medicago developed its H7N9 flu vaccine candide using its proprietary technology that produces vaccines from the leaves of tobacco plants....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Dr. Mike Walden
Tech economy
Frank Vinluan
Life science
Scroll